Linaglip-M 2.5 mg+500 mg (Tablet)
Unit Price: ৳ 14.00 (3 x 10: ৳ 420.00)
Strip Price: ৳ 140.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Linagliptin metformin hydrochloride |
| Company | Aristopharma ltd |
| Also available as |
Title
- Linagliptin & Metformin Hydrochloride Tablet
Categories
- Medicine
- Diabetes Care
- Oral Hypoglycemic
Description
- Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Linagliptin and Metformin Hydrochloride is appropriate
Dimensions
- Tablet size
Color Options
- Not applicable
Functions
- Improves glycemic control
- Inhibits DPP-4 enzyme
- Stimulates insulin release
- Decreases glucagon secretion
- Lowers postprandial plasma glucose
Materials
- Active ingredients: Linagliptin, Metformin Hydrochloride
- Inactive ingredients: to be inferred from the packaging
Technical Specifications
- Max recommended dose: 2.5 mg Linagliptin and 1000 mg Metformin Hydrochloride twice daily
- Dosage form: Immediate release tablet, Extended release tablet
Design Elements
- Film-coated
- Immediate release
- Extended release
Usability Features
- Individualized dosage based on effectiveness and tolerability
- Gradual dose escalation to reduce gastrointestinal side effects
- Once daily dosing
- Switching from individual components to combination therapy
Side Effects
- Nasopharyngitis
- Diarrhea
- Hypoglycemia
Pregnancy & Lactation
- Use during pregnancy only if clearly needed
- Caution advised during lactation
Precautions & Warnings
- Discontinue in case of lactic acidosis or pancreatitis
- Temporary discontinuation for radiologic studies or surgical procedures
- Monitoring of Vitamin B12 levels
- Guidance on alcohol consumption, other medicines, counseling, travel, and emergency preparedness
Overdose Effects
- Supportive measures in case of overdose
- Dialyzable property of Metformin Hydrochloride
- No dose-related adverse reactions observed with Linagliptin
- Hypoglycemia and lactic acidosis reported in Metformin Hydrochloride overdose cases
Therapeutic Class
- Combination Oral hypoglycemic preparations
Storage Conditions
- Cool & dry place below 30°C
- Protected from light & moisture
- Keep out of the reach of children